TCEAL7, a putative tumor suppressor gene, negatively regulates NF-B pathway

R. Rattan, K. Narita, J. Chien, J. L. Maguire, R. Shridhar, S. Giri, V. Shridhar

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We have previously shown that a frequently downregulated gene, transcription elongation factor A-like 7 (TCEAL7), promoted anchorage- independent growth and modulated Myc activity in ovarian surface epithelial cells immortalized with temperature-sensitive large T antigen and human telomerase reverse transcriptase (OSEtsT/hTERT). Analysis of protein/DNA array showed that TCEAL7 downregulation resulted in an approximately twofold increase in nuclear factor (NF)-B binding to its target DNA sequence. In this study we showed that short hairpin RNA (shRNA)-mediated downregulation of TCEAL7 in two different immortalized OSE cells showed higher NF-B activity, as determined using reporter and gel-shift assays. Transient transfection of TCEAL7 inhibited the activation of NF-B in TCEAL7-downregulated clones, IOSE-523 and in other ovarian cancer cell lines (OVCAR8, SKOV3ip and DOV13), suggesting that TCEAL7 negatively regulates NF-B pathway. Consistent with this observation, TCEAL7-downregulated clones showed higher levels of NF-B targets, such as pro-proliferative (cyclin-D1 and cMyc), pro-angiogenic (interleukin (IL)-6, IL-8 and vascular endothelial growth factor (VEGF)), inflammatory (intercellular adhesion molecule 1 (ICAM-1) and cyclooxygenase-2 (Cox-2)) and anti-apoptotic (B-cell lymphoma-extra large (Bcl-xl)) genes when compared with vector controls. Inhibition of NF-B by IB kinase (IKK) inhibitor (BMS 345541) attenuated cell survival and proliferation of TCEAL-knockdown clones. Although TCEAL7 inhibited p65 transcriptional activity, it did not modulate the cytoplasmic signaling of the NF-B pathway, by itself or by tumor necrosis factor-α (TNF-α). Chromatin immunoprecipitation (ChIP) assays revealed increased recruitment of p65 and p300 to the promoters of IL-8 and IL-6 in TCEAL7-downregulated clones. Collectively, these results indicate a novel role for TCEAL7 in the negative regulation of NF-B signaling at the basal level by modulating transcriptional activity of NF-B on its target gene promoters, potentially providing a novel mechanism by which NF-B activity may be deregulated in ovarian cancer cells.

Original languageEnglish (US)
Pages (from-to)1362-1373
Number of pages12
JournalOncogene
Volume29
Issue number9
DOIs
StatePublished - Mar 1 2010
Externally publishedYes

Fingerprint

Tumor Suppressor Genes
Down-Regulation
Clone Cells
Interleukin-8
Ovarian Neoplasms
Interleukin-6
transcription factor S-II
Genes
Protein Array Analysis
Chromatin Immunoprecipitation
Viral Tumor Antigens
Cyclin D1
B-Cell Lymphoma
Intercellular Adhesion Molecule-1
Cyclooxygenase 2
Oligonucleotide Array Sequence Analysis
Vascular Endothelial Growth Factor A
Small Interfering RNA
Transfection
Cell Survival

Keywords

  • NF-kB
  • Ovarian cancer
  • TCEAL7
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Rattan, R., Narita, K., Chien, J., Maguire, J. L., Shridhar, R., Giri, S., & Shridhar, V. (2010). TCEAL7, a putative tumor suppressor gene, negatively regulates NF-B pathway. Oncogene, 29(9), 1362-1373. https://doi.org/10.1038/onc.2009.431

TCEAL7, a putative tumor suppressor gene, negatively regulates NF-B pathway. / Rattan, R.; Narita, K.; Chien, J.; Maguire, J. L.; Shridhar, R.; Giri, S.; Shridhar, V.

In: Oncogene, Vol. 29, No. 9, 01.03.2010, p. 1362-1373.

Research output: Contribution to journalArticle

Rattan, R, Narita, K, Chien, J, Maguire, JL, Shridhar, R, Giri, S & Shridhar, V 2010, 'TCEAL7, a putative tumor suppressor gene, negatively regulates NF-B pathway', Oncogene, vol. 29, no. 9, pp. 1362-1373. https://doi.org/10.1038/onc.2009.431
Rattan R, Narita K, Chien J, Maguire JL, Shridhar R, Giri S et al. TCEAL7, a putative tumor suppressor gene, negatively regulates NF-B pathway. Oncogene. 2010 Mar 1;29(9):1362-1373. https://doi.org/10.1038/onc.2009.431
Rattan, R. ; Narita, K. ; Chien, J. ; Maguire, J. L. ; Shridhar, R. ; Giri, S. ; Shridhar, V. / TCEAL7, a putative tumor suppressor gene, negatively regulates NF-B pathway. In: Oncogene. 2010 ; Vol. 29, No. 9. pp. 1362-1373.
@article{f2ae3252b4b84577917ee56848c1d11f,
title = "TCEAL7, a putative tumor suppressor gene, negatively regulates NF-B pathway",
abstract = "We have previously shown that a frequently downregulated gene, transcription elongation factor A-like 7 (TCEAL7), promoted anchorage- independent growth and modulated Myc activity in ovarian surface epithelial cells immortalized with temperature-sensitive large T antigen and human telomerase reverse transcriptase (OSEtsT/hTERT). Analysis of protein/DNA array showed that TCEAL7 downregulation resulted in an approximately twofold increase in nuclear factor (NF)-B binding to its target DNA sequence. In this study we showed that short hairpin RNA (shRNA)-mediated downregulation of TCEAL7 in two different immortalized OSE cells showed higher NF-B activity, as determined using reporter and gel-shift assays. Transient transfection of TCEAL7 inhibited the activation of NF-B in TCEAL7-downregulated clones, IOSE-523 and in other ovarian cancer cell lines (OVCAR8, SKOV3ip and DOV13), suggesting that TCEAL7 negatively regulates NF-B pathway. Consistent with this observation, TCEAL7-downregulated clones showed higher levels of NF-B targets, such as pro-proliferative (cyclin-D1 and cMyc), pro-angiogenic (interleukin (IL)-6, IL-8 and vascular endothelial growth factor (VEGF)), inflammatory (intercellular adhesion molecule 1 (ICAM-1) and cyclooxygenase-2 (Cox-2)) and anti-apoptotic (B-cell lymphoma-extra large (Bcl-xl)) genes when compared with vector controls. Inhibition of NF-B by IB kinase (IKK) inhibitor (BMS 345541) attenuated cell survival and proliferation of TCEAL-knockdown clones. Although TCEAL7 inhibited p65 transcriptional activity, it did not modulate the cytoplasmic signaling of the NF-B pathway, by itself or by tumor necrosis factor-α (TNF-α). Chromatin immunoprecipitation (ChIP) assays revealed increased recruitment of p65 and p300 to the promoters of IL-8 and IL-6 in TCEAL7-downregulated clones. Collectively, these results indicate a novel role for TCEAL7 in the negative regulation of NF-B signaling at the basal level by modulating transcriptional activity of NF-B on its target gene promoters, potentially providing a novel mechanism by which NF-B activity may be deregulated in ovarian cancer cells.",
keywords = "NF-kB, Ovarian cancer, TCEAL7, Tumor suppressor gene",
author = "R. Rattan and K. Narita and J. Chien and Maguire, {J. L.} and R. Shridhar and S. Giri and V. Shridhar",
year = "2010",
month = "3",
day = "1",
doi = "10.1038/onc.2009.431",
language = "English (US)",
volume = "29",
pages = "1362--1373",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - TCEAL7, a putative tumor suppressor gene, negatively regulates NF-B pathway

AU - Rattan, R.

AU - Narita, K.

AU - Chien, J.

AU - Maguire, J. L.

AU - Shridhar, R.

AU - Giri, S.

AU - Shridhar, V.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - We have previously shown that a frequently downregulated gene, transcription elongation factor A-like 7 (TCEAL7), promoted anchorage- independent growth and modulated Myc activity in ovarian surface epithelial cells immortalized with temperature-sensitive large T antigen and human telomerase reverse transcriptase (OSEtsT/hTERT). Analysis of protein/DNA array showed that TCEAL7 downregulation resulted in an approximately twofold increase in nuclear factor (NF)-B binding to its target DNA sequence. In this study we showed that short hairpin RNA (shRNA)-mediated downregulation of TCEAL7 in two different immortalized OSE cells showed higher NF-B activity, as determined using reporter and gel-shift assays. Transient transfection of TCEAL7 inhibited the activation of NF-B in TCEAL7-downregulated clones, IOSE-523 and in other ovarian cancer cell lines (OVCAR8, SKOV3ip and DOV13), suggesting that TCEAL7 negatively regulates NF-B pathway. Consistent with this observation, TCEAL7-downregulated clones showed higher levels of NF-B targets, such as pro-proliferative (cyclin-D1 and cMyc), pro-angiogenic (interleukin (IL)-6, IL-8 and vascular endothelial growth factor (VEGF)), inflammatory (intercellular adhesion molecule 1 (ICAM-1) and cyclooxygenase-2 (Cox-2)) and anti-apoptotic (B-cell lymphoma-extra large (Bcl-xl)) genes when compared with vector controls. Inhibition of NF-B by IB kinase (IKK) inhibitor (BMS 345541) attenuated cell survival and proliferation of TCEAL-knockdown clones. Although TCEAL7 inhibited p65 transcriptional activity, it did not modulate the cytoplasmic signaling of the NF-B pathway, by itself or by tumor necrosis factor-α (TNF-α). Chromatin immunoprecipitation (ChIP) assays revealed increased recruitment of p65 and p300 to the promoters of IL-8 and IL-6 in TCEAL7-downregulated clones. Collectively, these results indicate a novel role for TCEAL7 in the negative regulation of NF-B signaling at the basal level by modulating transcriptional activity of NF-B on its target gene promoters, potentially providing a novel mechanism by which NF-B activity may be deregulated in ovarian cancer cells.

AB - We have previously shown that a frequently downregulated gene, transcription elongation factor A-like 7 (TCEAL7), promoted anchorage- independent growth and modulated Myc activity in ovarian surface epithelial cells immortalized with temperature-sensitive large T antigen and human telomerase reverse transcriptase (OSEtsT/hTERT). Analysis of protein/DNA array showed that TCEAL7 downregulation resulted in an approximately twofold increase in nuclear factor (NF)-B binding to its target DNA sequence. In this study we showed that short hairpin RNA (shRNA)-mediated downregulation of TCEAL7 in two different immortalized OSE cells showed higher NF-B activity, as determined using reporter and gel-shift assays. Transient transfection of TCEAL7 inhibited the activation of NF-B in TCEAL7-downregulated clones, IOSE-523 and in other ovarian cancer cell lines (OVCAR8, SKOV3ip and DOV13), suggesting that TCEAL7 negatively regulates NF-B pathway. Consistent with this observation, TCEAL7-downregulated clones showed higher levels of NF-B targets, such as pro-proliferative (cyclin-D1 and cMyc), pro-angiogenic (interleukin (IL)-6, IL-8 and vascular endothelial growth factor (VEGF)), inflammatory (intercellular adhesion molecule 1 (ICAM-1) and cyclooxygenase-2 (Cox-2)) and anti-apoptotic (B-cell lymphoma-extra large (Bcl-xl)) genes when compared with vector controls. Inhibition of NF-B by IB kinase (IKK) inhibitor (BMS 345541) attenuated cell survival and proliferation of TCEAL-knockdown clones. Although TCEAL7 inhibited p65 transcriptional activity, it did not modulate the cytoplasmic signaling of the NF-B pathway, by itself or by tumor necrosis factor-α (TNF-α). Chromatin immunoprecipitation (ChIP) assays revealed increased recruitment of p65 and p300 to the promoters of IL-8 and IL-6 in TCEAL7-downregulated clones. Collectively, these results indicate a novel role for TCEAL7 in the negative regulation of NF-B signaling at the basal level by modulating transcriptional activity of NF-B on its target gene promoters, potentially providing a novel mechanism by which NF-B activity may be deregulated in ovarian cancer cells.

KW - NF-kB

KW - Ovarian cancer

KW - TCEAL7

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=77949265985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949265985&partnerID=8YFLogxK

U2 - 10.1038/onc.2009.431

DO - 10.1038/onc.2009.431

M3 - Article

C2 - 19966855

AN - SCOPUS:77949265985

VL - 29

SP - 1362

EP - 1373

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 9

ER -